As of August 2019, the Danish pharmaceutical company Novo Nordisk controlled about 77 percent of the premix insulin market in Greater China. Overall, its leadership in the Chinese insulin market dropped slightly compared to the previous year, whereas local insulin manufacturers held around 33 percent of the market. Founded in 1923, the firm specializes in producing diabetes medications, which accounted for 80 percent of its annual sales revenue in 2019.
Market share of Novo Nordisk in the insulin market in Greater China as of August 2019, by insulin type
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Novo Nordisk. (September 1, 2019). Market share of Novo Nordisk in the insulin market in Greater China as of August 2019, by insulin type [Graph]. In Statista. Retrieved December 21, 2024, from https://www.statista.com/statistics/1122587/greater-china-insulin-market-share-of-novo-nordisk-by-segment/
Novo Nordisk. "Market share of Novo Nordisk in the insulin market in Greater China as of August 2019, by insulin type." Chart. September 1, 2019. Statista. Accessed December 21, 2024. https://www.statista.com/statistics/1122587/greater-china-insulin-market-share-of-novo-nordisk-by-segment/
Novo Nordisk. (2019). Market share of Novo Nordisk in the insulin market in Greater China as of August 2019, by insulin type. Statista. Statista Inc.. Accessed: December 21, 2024. https://www.statista.com/statistics/1122587/greater-china-insulin-market-share-of-novo-nordisk-by-segment/
Novo Nordisk. "Market Share of Novo Nordisk in The Insulin Market in Greater China as of August 2019, by Insulin Type." Statista, Statista Inc., 1 Sep 2019, https://www.statista.com/statistics/1122587/greater-china-insulin-market-share-of-novo-nordisk-by-segment/
Novo Nordisk, Market share of Novo Nordisk in the insulin market in Greater China as of August 2019, by insulin type Statista, https://www.statista.com/statistics/1122587/greater-china-insulin-market-share-of-novo-nordisk-by-segment/ (last visited December 21, 2024)
Market share of Novo Nordisk in the insulin market in Greater China as of August 2019, by insulin type [Graph], Novo Nordisk, September 1, 2019. [Online]. Available: https://www.statista.com/statistics/1122587/greater-china-insulin-market-share-of-novo-nordisk-by-segment/
